| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ERI.10.92 |
| P698 | PubMed publication ID | 20818943 |
| P50 | author | Bernard-alex Gauzere | Q42637235 |
| Pascale Krejbich-Trotot | Q45880107 | ||
| Marie-Christine Jaffar-Bandjee | Q45880156 | ||
| Philippe Gasque | Q59668588 | ||
| P2093 | author name string | Anne Ribera | |
| Duksha Ramful | |||
| Jean Jacques Hoarau | |||
| Stephanie Robin | |||
| Jimmy Selambarom | |||
| P2860 | cites work | Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus | Q21090106 |
| A single mutation in chikungunya virus affects vector specificity and epidemic potential | Q21131599 | ||
| Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak | Q21144706 | ||
| A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease | Q21559504 | ||
| Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period | Q21562272 | ||
| Aedes albopictus in the United States: ten-year presence and public health implications | Q24288620 | ||
| Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages | Q24288996 | ||
| Chikungunya, an epidemic arbovirosis | Q24291001 | ||
| Ross River virus transmission, infection, and disease: a cross-disciplinary review | Q24550672 | ||
| A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection | Q24631774 | ||
| Chikungunya virus takes centre stage in virally induced arthritis: possible cellular and molecular mechanisms to pathogenesis | Q37616326 | ||
| Arthritides Caused by Mosquito-Borne Viruses | Q39518398 | ||
| Prevention with repellent in children | Q40376613 | ||
| Clinical profile of Chikungunya in infants | Q40393552 | ||
| Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion | Q40412307 | ||
| A226V mutation in virus during the 2007 chikungunya outbreak in Kerala, India. | Q40414131 | ||
| Clinical features and molecular diagnosis of Chikungunya fever from South India | Q40421490 | ||
| Seroprevalence of five arboviruses in Zebu cattle in the Central African Republic | Q40675363 | ||
| Persistence of alphaviruses in vertebrate hosts | Q40742861 | ||
| Chikungunya virus aches and pains: an emerging challenge | Q41940293 | ||
| Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa | Q42062705 | ||
| RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells | Q43824146 | ||
| Neurologic manifestations of pediatric chikungunya infection | Q44140290 | ||
| A destructive arthropathy following Chikungunya virus arthritis--a possible association | Q44164039 | ||
| Development of an attenuated strain of chikungunya virus for use in vaccine production | Q44523303 | ||
| Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases | Q44850643 | ||
| Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. | Q44850657 | ||
| Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island | Q44851009 | ||
| Chikungunya and respiratory viral infections | Q44851176 | ||
| Chikungunya epidemic in India: a major public-health disaster | Q44851348 | ||
| Immunologic interference from sequential administration of live attenuated alphavirus vaccines. | Q44851631 | ||
| A case of bilateral presumed chikungunya neuroretinitis | Q24658249 | ||
| The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic | Q27469278 | ||
| Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion | Q27485485 | ||
| Chikungunya Fever in Travelers Returning to Europe from the Indian Ocean Region, 2006 | Q27487088 | ||
| Chimeric alphavirus vaccine candidates for chikungunya | Q27487105 | ||
| Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus | Q27487330 | ||
| IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity | Q27487567 | ||
| Chikungunya Virus and Central Nervous System Infections in Children, India | Q27488268 | ||
| Guillain-Barré Syndrome after Chikungunya Infection | Q27488380 | ||
| Chikungunya Outbreak, Singapore, 2008 | Q27488425 | ||
| The Crystal Structures of Chikungunya and Venezuelan Equine Encephalitis Virus nsP3 Macro Domains Define a Conserved Adenosine Binding Pocket | Q27488798 | ||
| Impact of Chikungunya Virus Infection on Health Status and Quality of Life: A Retrospective Cohort Study | Q27490293 | ||
| Genetic analysis of chikungunya viruses imported to mainland China in 2008 | Q27491013 | ||
| Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness | Q27491022 | ||
| Infection with chikungunya virus in Italy: an outbreak in a temperate region | Q29346487 | ||
| Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus | Q29620003 | ||
| An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features | Q29620004 | ||
| Chikungunya: a potentially emerging epidemic? | Q30388754 | ||
| Impact of climate change and other factors on emerging arbovirus diseases | Q33370244 | ||
| Vertical maternal fetal transmission of the chikungunya virus. Ten cases among 84 pregnant women | Q33371256 | ||
| Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients | Q33375141 | ||
| Mother-to-child transmission of Chikungunya virus infection | Q33376362 | ||
| Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies | Q33517926 | ||
| Cutaneous manifestations in patients suspected of chikungunya disease | Q33593246 | ||
| Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. | Q34013185 | ||
| Chikungunya virus arthritis in adult wild-type mice | Q34046030 | ||
| Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging | Q34099818 | ||
| Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | Q34110965 | ||
| Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses | Q34327466 | ||
| Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases | Q34579545 | ||
| Prophylaxis and therapy for Chikungunya virus infection | Q34990306 | ||
| Novel chikungunya virus variant in travelers returning from Indian Ocean islands | Q35792249 | ||
| Alphaviruses: an emerging cause of arthritis? | Q37182515 | ||
| Immuno-biology of Chikungunya and implications for disease intervention | Q37593713 | ||
| Chikungunya: a bending reality | Q37595871 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| chikungunya | Q243257 | ||
| Chikungunya virus | Q15794049 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 987-996 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Emergence and clinical insights into the pathology of Chikungunya virus infection | |
| P478 | volume | 8 |
| Q44141937 | A rationale to design longer lasting mosquito repellents |
| Q34273343 | Arthritogenic alphaviruses--an overview |
| Q31047811 | Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage |
| Q24701786 | Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes |
| Q34306990 | Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a Chikungunya virus-like particle vaccine |
| Q26851337 | Emerging and re-emerging viruses: A global challenge illustrated by Chikungunya virus outbreaks |
| Q50099518 | Evidence of previous but not current transmission of chikungunya virus in southern and central Vietnam: Results from a systematic review and a seroprevalence study in four locations |
| Q92072015 | Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate |
| Q37331952 | Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis |
| Q38234431 | Global protein profiling studies of chikungunya virus infection identify different proteins but common biological processes |
| Q47548537 | Guillain-Barré syndrome, transverse myelitis and infectious diseases. |
| Q38862736 | Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment |
| Q28275508 | Identification of prohibitin as a Chikungunya virus receptor protein |
| Q39024665 | Improved detection of genus-specific Alphavirus using a generic TaqMan® assay |
| Q41857816 | Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis |
| Q39223670 | Mouse macrophage innate immune response to Chikungunya virus infection |
| Q24701792 | Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection |
| Q36276696 | Myd88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice |
| Q34238705 | Proteomic analysis of chikungunya virus infected microgial cells |
| Q35238179 | Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge |
| Q93087252 | Rheumatic manifestations of chikungunya: emerging concepts and interventions |
| Q61818328 | Risk factors for hospitalization of patients with chikungunya virus infection at sentinel hospitals in Puerto Rico |
| Q42199381 | Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial |
| Q59352325 | Sindbis Virus Infection Causes Cell Death by nsP2-Induced Transcriptional Shutoff or by nsP3-Dependent Translational Shutoff |
| Q66679599 | Systems analysis of subjects acutely infected with the Chikungunya virus |
| Q35808656 | The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody Recognition |
| Q40283972 | The cell biology of Chikungunya virus infection |
| Q44843998 | Ultrasonography of Hands and Wrists in the Diagnosis of Complications of Chikungunya Fever. |
Search more.